Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Mossanen

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Urology|March 8, 2017
Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United StatesRoss E Krasnow, Matthew Mossanen, Sophia Koo, et al.
European Urology Oncology|May 18, 2019
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical ProstatectomyMatthew Mossanen, Kenneth G Nepple, Robert L Grubb, et al.
The Journal of Urology|September 9, 2014
Overuse of antimicrobial prophylaxis in community practice urologyMatthew Mossanen, Joshua K Calvert, Sarah K Holt, et al.
Journal of Interprofessional Care|March 10, 2017
Individual, interpersonal, and organisational factors of healthcare conflict: A scoping reviewSara Kim, Naike Bochatay, Annemarie Relyea-Chew, et al.
Urologic Oncology|March 19, 2021
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinomaMarco Paciotti, David-Dan Nguyen, Daniele Modonutti, et al.
Urology|August 18, 2020
Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?Karl H Tully, Alexander P Cole, Marieke J Krimphove, et al.
Journal of Clinical Medicine|November 14, 2023
Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder CancerVincent D D'Andrea, Kevin Melnick, Kendrick Yim, et al.
World Journal of Urology|November 18, 2018
Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categoriesMatthew Mossanen, Ye Wang, Julie Szymaniak, et al.
Urology|April 9, 2020
Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical CystectomyJay Tzu-Hao Huang, Alexander P Cole, Matthew Mossanen, et al.
Urologic Oncology|November 26, 2019
Risk factors and reasons for reoperation after radical cystectomyStephen W Reese, Emily Ji, Marco Paciotti, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Urology|March 8, 2017
Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United StatesRoss E Krasnow, Matthew Mossanen, Sophia Koo, et al.
European Urology Oncology|May 18, 2019
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical ProstatectomyMatthew Mossanen, Kenneth G Nepple, Robert L Grubb, et al.
The Journal of Urology|September 9, 2014
Overuse of antimicrobial prophylaxis in community practice urologyMatthew Mossanen, Joshua K Calvert, Sarah K Holt, et al.
Journal of Interprofessional Care|March 10, 2017
Individual, interpersonal, and organisational factors of healthcare conflict: A scoping reviewSara Kim, Naike Bochatay, Annemarie Relyea-Chew, et al.
Urologic Oncology|March 19, 2021
Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinomaMarco Paciotti, David-Dan Nguyen, Daniele Modonutti, et al.
Urology|August 18, 2020
Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?Karl H Tully, Alexander P Cole, Marieke J Krimphove, et al.
Journal of Clinical Medicine|November 14, 2023
Evidence-Based Analysis of the Critical Steps of Radical Cystectomy for Bladder CancerVincent D D'Andrea, Kevin Melnick, Kendrick Yim, et al.
World Journal of Urology|November 18, 2018
Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categoriesMatthew Mossanen, Ye Wang, Julie Szymaniak, et al.
Urology|April 9, 2020
Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical CystectomyJay Tzu-Hao Huang, Alexander P Cole, Matthew Mossanen, et al.
Urologic Oncology|November 26, 2019
Risk factors and reasons for reoperation after radical cystectomyStephen W Reese, Emily Ji, Marco Paciotti, et al.
Pageof 13